Diagnostic value of urinary biomarkers excretion in estimation of morphological lesions in patients with primary glomerulopathies
- Authors: Saganova E.S.1, Zubina I.M.1, Bogdanova E.O.1, Galkina O.V.1, Sipovskii V.G.1, Smirnov A.V.1
-
Affiliations:
- Pavlov First Saint Petersburg State Medical University
- Issue: Vol 93, No 6 (2021)
- Pages: 699-705
- Section: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/75962
- DOI: https://doi.org/10.26442/00403660.2021.06.200850
- ID: 75962
Cite item
Full Text
Abstract
Aim. To investigate the diagnostic value of biomarkers in assessing the severity of sclerotic and atrophic lesions in primary glomerulopathies.
Materials and methods. One hundred patients were included in the study, according to the results of kidney biopsy in 9 (9%) cases minimal change disease was diagnosed, in 28 (28%) – focal segmental glomerulosclerosis, in 26 (26%) – membranous nephropathy and in 37 (37%) – IgA nephropathy. The clinical course of nephropathy was evaluated, standard laboratory tests were performed, and urinary excretions of cystatin C, α1-microglobulin, β2-microglobulin and NGAL were measured. The degree of glomerulosclerosis was assessed quantitatively, tubulointerstitial sclerosis and tubular atrophy – semiquantitatively.
Results. According to the results of linear correlations and ROC-analysis, urinary excretion of cystatin C and α1-microglobulin had diagnostic value for early degree of tubulointerstitial sclerosis (cut-off value 319.9 and 10.94 mg/day, respectively). Urinary excretion of β2-microglobulin reflected the initial degree of tubalar atrophy (cut-off value of 0.224 mcg/day), as well as tubulointerstitial sclerosis of various degrees of severity (cut-off value 0.224 and 0.240 mkg/day). NGAL urinary excretion was the only marker of early degree of glomerulosclerosis with its excretion of more than 1445.4 ng/day and tubular atrophy, with a severity of 50% or more (cut-off value 4897.8 ng/day).
Conclusion. A comprehensive assessment of sclerotic and atrophic lesions in the renal parenchyma, can be performed using a panel of traditional (GFR, proteinuria) and specific biomarkers (α1-, β2-microglobulins, cystatin C, NGAL) to implement a comprehensive, personalized approach, as well as to assess the prognosis of nephropathy. In addition, the evaluation of the panel of different biomarkers can be used in those clinical situations where kidney biopsy can not be performed.
Full Text
##article.viewOnOriginalSite##About the authors
Elena S. Saganova
Pavlov First Saint Petersburg State Medical University
Author for correspondence.
Email: nephrolog1985@gmail.com
ORCID iD: 0000-0002-9850-1107
канд. мед. наук, врач-нефролог
Russian Federation, Saint PetersburgIrina M. Zubina
Pavlov First Saint Petersburg State Medical University
Email: nephrolog1985@gmail.com
ORCID iD: 0000-0001-8491-7016
канд. биол. наук, ст. науч. сотр.
Russian Federation, Saint PetersburgEvdokiia O. Bogdanova
Pavlov First Saint Petersburg State Medical University
Email: nephrolog1985@gmail.com
ORCID iD: 0000-0003-1969-1959
канд. биол. наук, науч. сотр.
Russian Federation, Saint PetersburgOlga V. Galkina
Pavlov First Saint Petersburg State Medical University
Email: nephrolog1985@gmail.com
ORCID iD: 0000-0001-7265-7392
канд. биол. наук, зав. лаб. биохимического гомеостаза
Russian Federation, Saint PetersburgVasilii G. Sipovskii
Pavlov First Saint Petersburg State Medical University
Email: nephrolog1985@gmail.com
ORCID iD: 0000-0002-1512-8037
канд. мед. наук, зав. лаб. морфологии и клинической иммунологии
Russian Federation, Saint PetersburgAleksei V. Smirnov
Pavlov First Saint Petersburg State Medical University
Email: nephrolog1985@gmail.com
ORCID iD: 0000-0001-7863-9080
д-р мед. наук, проф., дир.
Russian Federation, Saint PetersburgReferences
- Luciano RL, Moeckel GW. Update on the Native Kidney Biopsy: Core Curriculum 2019. Am J Kidney Dis. 2019;73(3):404-15. doi: 10.1053/j.ajkd.2018.10.011
- Glassock RJ. Con: Kidney biopsy: an irreplaceable tool for patient management in nephrology. Nephrol Dial Transplant. 2015;30(4):528-31. doi: 10.1093/ndt/gfv044
- Tan M, Li W, Zou G, et al. Clinicopathological features and outcomes of IgA nephropathy with hematuria and/or minimal proteinuria. Kidney Blood Press Res. 2015;40(2):200-6. doi: 10.1159/000368495
- Ren H, Shen P, Li X, et al. Treatment and prognosis of primary focal segmental glomerulosclerosis. Contrib Nephrol. 2013;181:109-18. doi: 10.1159/000348468
- Mischak H, Delles C, Vlahou A, Vanholder R. Proteomic biomarkers in kidney disease: issues in development and implementation. Nat Rev Nephrol. 2015;11(4):221-32. doi: 10.1038/nrneph.2014.247
- Siwy J, Zürbig P, Argiles A, et al. Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis. Nephrol Dial Transplant. 2017;32(12):2079-89. doi: 10.1093/ndt/gfw337
- Good DM, Zürbig P, Argilés A, et al. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics. 2010;9(11):2424-37. doi: 10.1074/mcp.M110.001917
- Gold L, Ayers D, Bertino J, et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One. 2010;5(12):e15004. doi: 10.1371/journal.pone.0015004
- Пролетов Я.Ю., Саганова Е.С., Галкина О.В., и др. Диагностическая значимость цистатина С и нейтрофильного липокалина, ассоциированного с желатиназой, при первичных гломерулопатиях. Терапевтический архив. 2013;85(6):10-6 [Proletov IaIu, Saganova ES, Galkina OV, et al. Diagnostic value of cystatin C and neutrophil gelatinase-associated lipocalin in primary glomerulopathies. Terapevticheskii Arkhiv (Ter. Arkh.). 2013;85(6):10-6 (in Russian)].
- Fassett RG, Venuthurupalli SK, Gobe GC, Coombes JS, Cooper MA, Hoy WE. Biomarkers in chronic kidney disease: a review. Kidney Int. 2011;80(8):806-21. doi: 10.1038/ki.2011.198
- Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(2):337-44. doi: 10.2215/CJN.03530708
- Смирнов А.В., Хасун М., Каюков И.Г., и др. Уромодулин и выраженность тубулоинтерстициальных повреждений у пациентов с нефропатиями. Нефрология. 2015;19(2):49-54 [Smirnov AV, Khasun M, Kayukov IG, et al. Uromodulin and severity of tubulointerstitial lesions in patients with nephropathies. Nephrology. 2015;19(2):49-54 (in Russian)].
- van den Brand JA, Hofstra JM, Wetzels JFM. Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2011;6(12):2846-53. doi: 10.2215/CJN.04020411
- Peters HPE, van den Brand JA, Wetzels JFM. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy. Neth J Med. 2009;67(2):54-61
- Kee YK, Yoon C-Y, Kim SJ, et al. Determination of the optimal target level of proteinuria in the management of patients with glomerular diseases by using different definitions of proteinuria. Medicine (Baltimore). 2017;96(44):e8154. doi: 10.1097/MD.0000000000008154
- Кушнаренко Н.Н., Медведева Т.А., Говорин А.В., Мишко М.Ю. Цистатин С в диагностике преклинического поражения почек у больных с подагрой. Нефрология. 2018;22(1):75-82 [Kushnarenko NN, Medvedeva TA, Govorin AV, Mishko MY. Cystatin c in the diagnosis of pre-clinical kidney injury in patients with gout. Nephrology. 2018;22(1):75-82 (in Russian)]. doi: 10.24884/1561-6274-2018-22-1-75-82
- Еремеева А.В., Длин В.В., Корсунский А.А., и др. Клиническое значение определения липокалина-2, ассоциированного с нейтрофильной желатиназой, у пациентов с хронической болезнью почек (обзор литературы). Нефрология. 2018;22(4):50-6 [Eremeeva AV, Dlin VV, Korsunsky AA, et al. Clinical significance of determination of lipocalin-2 associated with neutrophilic gelatinase in patients with chronic kidney disease (literature review). Nephrology. 2018;22(4):50-6 (in Russian)]. doi: 10.24884/1561-6274-2018-22-4-50-56
- Reich HN, Troyanov S, Scholey JW, Cattran DC. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol. 2007;18(12):3177-83. doi: 10.1681/ASN.2007050526
- Bazzi C, Rizza V, Casellato D, et al. Fractional excretion of IgG in idiopathic membranous nephropathy with nephrotic syndrome: a predictive marker of risk and drug responsiveness. BMC Nephrol. 2014;15:74. doi: 10.1186/1471-2369-15-74
- Bazzi C, Petrini C, Rizza V, et al. Urinary excretion of IgG and alpha(1)-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy. Am J Kidney Dis. 2001;38(2):240-8. doi: 10.1053/ajkd.2001.26080
- Branten AJW, Du Buf-Vereijken PW, Klasen IS, et al. Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study. J Am Soc Nephrol. 2005;16(1):169-74. doi: 10.1681/ASN.2004040287
- Shin JR, Kim SM, Yoo JS, et al. Urinary excretion of beta2-microglobulin as a prognostic marker in immunoglobulin A nephropathy. Korean J Intern Med. 2014;29(3):334-40. doi: 10.3904/kjim.2014.29.3.334
- Nielsen R, Christensen EI, Birn H. Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease. Kidney Int. 2016;89(1):58-67. doi: 10.1016/j.kint.2015.11.007
- Patel ML, Sachan R, Verma A, et al. Neutrophil gelatinase-associated lipocalin as a biomarker of disease progression in patients with chronic kidney disease. Indian J Nephrol. 2016;26(2):125-30. doi: 10.4103/0971-4065.157799
- Patel ML, Sachan R, Misra R, et al. Prognostic significance of urinary NGAL in chronic kidney disease. Int J Nephrol Renovasc Dis. 2015;8:139-44. doi: 10.2147/IJNRD.S87423
- Nickolas TL, Forster CS, Sise ME, et al. NGAL (Lcn2) monomer is associated with tubulointerstitial damage in chronic kidney disease. Kidney Int. 2012;82(6):718-22. doi: 10.1038/ki.2012.195
- Ding H, He Y, Li K, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol. 2007;123(2):227-34. doi: 10.1016/j.clim.2007.01.010
- Пролетов Я.Ю., Саганова Е.С., Галкина О.В., и др. Роль некоторых биомаркеров в оценке характера хронического повреждения почек у пациентов с первичными гломерулопатиями. Нефрология. 2013;17(1):60-9 [Proletov II, Saganova ES, Galkina OV, et al. The role of several biomarkers in estimation of kidney injury in patients with primary glomerulopathies. Nephrology. 2013;17(1):60-9 (in Russian)]. doi: 10.24884/1561-6274-2013-17-1-60-69
- Rhee H, Shin N, Shin MJ, et al. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy. Korean J Intern Med. 2015;30(3):354-61. doi: 10.3904/kjim.2015.30.3.354